🚧 Under construction — Data may be inaccurate or incomplete. We're actively adding more companies and financial metrics.

Macquarie Group Limited vs Regeneron Pharmaceuticals, Inc.

Market cap comparison over time

Macquarie Group Limited

$60.1B

Rank #236

Regeneron Pharmaceuticals, Inc.

$63.0B

Rank #231

Market Cap Over Time

Key Moments

  • Macquarie Group Limited overtook Regeneron Pharmaceuticals, Inc. by 1998
  • Regeneron Pharmaceuticals, Inc. overtook Macquarie Group Limited by 2000
  • Macquarie Group Limited overtook Regeneron Pharmaceuticals, Inc. by 2001
  • Regeneron Pharmaceuticals, Inc. overtook Macquarie Group Limited by 2011

Year-by-Year Comparison

YearMacquarie Group LimitedRegeneron Pharmaceuticals, Inc.Leader
2026$60.1B$63.0BRegeneron Pharmaceuticals, Inc.
2025$49.5B$79.3BRegeneron Pharmaceuticals, Inc.
2024$52.2B$72.8BRegeneron Pharmaceuticals, Inc.
2023$41.9B$89.7BRegeneron Pharmaceuticals, Inc.
2022$36.6B$73.7BRegeneron Pharmaceuticals, Inc.
2021$43.4B$64.5BRegeneron Pharmaceuticals, Inc.
2020$28.2B$49.4BRegeneron Pharmaceuticals, Inc.
2019$27.4B$38.4BRegeneron Pharmaceuticals, Inc.
2018$20.6B$38.2BRegeneron Pharmaceuticals, Inc.
2017$18.0B$38.4BRegeneron Pharmaceuticals, Inc.
2016$14.9B$37.5BRegeneron Pharmaceuticals, Inc.
2015$13.4B$55.5BRegeneron Pharmaceuticals, Inc.
2014$9.0B$41.9BRegeneron Pharmaceuticals, Inc.
2013$8.1B$28.1BRegeneron Pharmaceuticals, Inc.
2012$4.9B$17.5BRegeneron Pharmaceuticals, Inc.
2011$3.1B$5.7BRegeneron Pharmaceuticals, Inc.
2010$4.6B$3.4BMacquarie Group Limited
2009$5.7B$2.5BMacquarie Group Limited
2008$3.3B$1.9BMacquarie Group Limited
2007$7.7B$2.5BMacquarie Group Limited
2006$7.8B$2.1BMacquarie Group Limited
2005$6.5B$1.6BMacquarie Group Limited
2004$4.2B$941.1MMacquarie Group Limited
2003$3.1B$1.5BMacquarie Group Limited
2002$2.0B$1.9BMacquarie Group Limited
2001$3.1B$2.9BMacquarie Group Limited
2000$2.3B$3.6BRegeneron Pharmaceuticals, Inc.
1999$2.0B$1.3BMacquarie Group Limited
1998$1.2B$753.6MMacquarie Group Limited
1997$827.4M$874.9MRegeneron Pharmaceuticals, Inc.
1996$528.3M$1.6BRegeneron Pharmaceuticals, Inc.